A Multiple Dose Study of the Safety and Pharmacology of LY2165766
Completed
- Conditions
- Schizophrenia10039628
- Registration Number
- NL-OMON33078
- Lead Sponsor
- Chorus LRL (Division of Eli Lilly)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Healthy male 18 - 65
Healthy female 45 - 65 postmenopausal/sterilised
BMI 18.5 - 32
Exclusion Criteria
Relevant medical history
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method